维普中文期刊产品整合服务
646篇 您的检索式:作者名="Goldstein I"
    题名 作者 年代 出处 被引量
12018加拿大心境障碍与焦虑障碍治疗协作组/国际双相障碍学会指南:双相障碍的管理显示文摘加拿大心境障碍与焦虑障碍治疗协作组(Canadian Network for Mood and Anxiety Treatments,CANMAT)曾于2005年发布了第1版双相障碍管理指南,并分别于2007、2009和2013年对该指南进行了更新,其中最近的2次更新是与国际双相障碍学会(International Society for Bipolar Disorders,ISBD)合作完成。2018版CANMAT/ISBD双相障碍治疗指南(以下简称指南)反映了自2005年首版指南发表以来本领域取得的重大进展,包括疾病诊断与疾病管理的更新以及药物治疗与心理治疗的近期研究进展。这些前沿进展中综合考虑了循证证据的级别,并基于治疗疗效、临床实践经验、安全性、耐受性和药物导致的转相风险等,对一线、二线及三线治疗方案进行了简明而清晰的推荐。本指南中新增内容涵盖了双相Ⅰ型障碍(BD-Ⅰ)的躁狂发作急性期、抑郁发作急性期和双相障碍维持期的一线及二线治疗推荐等级划分。这种对治疗推荐等级的划分综合考虑了治疗方法对双相障碍不同时相的影响,将进一步帮助临床医生做出基于循证证据的治疗决策。锂盐、喹硫平、双丙戊酸盐、阿塞那平、阿立哌唑、帕利哌酮、利培酮和卡利拉嗪单药或联合使用被推荐为躁狂发作急性期的一线治疗选择。BD-Ⅰ抑郁期的一线治疗选择包括喹硫平、鲁拉西酮、锂盐、拉莫三嗪单药,鲁拉西酮联合锂盐或双丙戊酸盐或拉莫三嗪辅助治疗。尽管急性期治疗有效的药物通常应继续用于BD-Ⅰ的维持期治疗,但也存在一些特殊情况(例如抗抑郁药)。现有数据表明,锂盐、喹硫平、双丙戊酸盐、拉莫三嗪、阿塞那平和阿立哌唑单药或联合治疗应被视为维持治疗的初始或更换治疗方案时的一线选择。除了探讨BD-Ⅰ的相关问题外,本指南中还对双相Ⅱ型障碍(BD-Ⅱ)的临床管理进行了系统回顾并给予治疗推荐,同时针对特殊人群也有相关推荐,如处于各个生殖周期的女性、儿童、青少年和老年人。此外,本指南中还讨论了特定精神疾病及共病(如物质滥用、焦虑障碍和代谢性疾病)的影响。最后,本指南中概述了安全性和药物监测的相关问题。CANMAT/ISBD工作组希望本指南能够成为全球临床医生的实用工具。Lakshmi N Yatham Sidney H Kennedy Sagar V Parikh Ayal Sehaffer David J Bond Benicio N Frey Verinder Sharma Benjamin I Goldstein Soham Rej Serge Beaulieu Martin Alda Glenda MaeQueen Roumen V Milev Arun Ravindran Claire O'Donovan Diane Mclntosh Raymond W Lam Gustavo Vazquez Flavio Kapczinski Roger S Melntyre Jan Kozicky Shigenobu Kanba Beny Lafer Trisha Suppes Joseph R Calabrese Eduard Vieta Gin Malhi Robert M Post Michael Berk 胡晨(译) 王刚(译) 2019中华精神科杂志2019,52,1:25
2An interative method for the Helmholtz equation显示文摘Bayliss S Goldstein C I Turkel E 1983J Comput Phys1983,49,:1
3Brown Bear Den Habitat and Winter Recreation in South- Central Alaska显示文摘Goldstein M I Poe A J Suring L H Nielson R M Mcdonald T L 2010Journal of Wildlife Management2010,74,1:1
4Solidification of M2 High Speed Steel显示文摘Barkalow R H Kraft R W Goldstein J I 1972Metallurgical Transactions1972,,3:1
5Impotence and its medical and psychosocial correlations: results of the Massachusetts male aging study 显示文摘Tenover J Feldman H A Goldstein I 1994J Urol1994,151,1:1
6A Multistage Representation of the Wiener Filter Based on Orthogonal Projections显示文摘Goldstein J S Reed I S Scharf L L 1998IEEE Transactions on Information Theory1998,44,7:1
7A multistage representation of the wiener filter based on orthogonal projection显示文摘Goldstein J S Reed I S Scharf L L 1998IEEE Transactions on Information Theory1998,44,7:1
8Sonographic assessment of the distal femoral and proximal tibial ossification centers in the prediction of pulmonic maturity in normal women and women with diabetes显示文摘Goldstein I Lockwood CJ Reece EA 0,,01:1
9Comparative diagnostic performances of auscultation, chest radiography, and lung ultrasonography in acute respiratory distress syndrome显示文摘Lichtenstein D Goldstein I Mourgeon E 2004Anesthesiology2004,100,1:1
10Avanafil for the treatment of erectile dysfunction:a multicenter,randomized,double-blind study in men with diabetes mellitus显示文摘GOLDSTEIN I JONES LA BELKOFF LH 2012Mayo Clin Proc2012,87,9:1
11Preconditioned conjugate gradient methods for the Helmholtz equation显示文摘Bayliss S Goldstein C I Turkel E 1984Elliptic Problem Solvers Ⅱ1984,,:1
12Potassium leak channels and the KCNK family of two-P- domain subunits显示文摘Goldstein SA Bockenhauer D O'Kelly I 2001Nat Rev Neurosci2001,2,3:1
13A multistage repre- sentation of the Wiener filter based on orthogonal projec- tions 显示文摘Goldstein J S Reed I S Scharf L L 1998IEEE Transactions on Information Theory1998,44,7:1
14Novel genes implicated in embryonal,alveolar,and pleomorphic rhabdomyosarcoma: A cyto- genetic and molecular analysis of primary tumors显示文摘Goldstein M Meller I Issakov J 2006Neoplasia2006,8,:1
15Understanding wild-type and mutant p53 activities in human cancer:new landmarks on the way to targeted therapies显示文摘Goldstein I Marcel V Olivier M 2011Cancer Gene Ther2011,18,1:1
16The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction显示文摘GOLDSTEIN I 2000Am J Cardiol2000,86,2:1
17A multistage representation of the wiener filter based on orthogonal projections 显示文摘J S Goldstein I S Reed L L Scharf 1998IEEE Transactions on Information Theory1998,44,7:1
18Oral sildenafil in the treatment of erectile dysfunction显示文摘Goldstein I Lue TF Padma-Nathan H 1998N Engl J Med1998,338,:1
19Vardenafil,a new phosphodiesterase type 5 inhibitor,in the treatment of erectile dysfunction in men with diabetes:a multicenter double-blind placebo-controlled fixed-dose study显示文摘Goldstein I Young JM Fischer J 2003Diabetes Care2003,26,3:1
20Impotencean dits medical and psychosocial correlates:results of the massachusetts male aging study显示文摘Feldman H A Goldstein I Hatzichristou D G 1994J Urol1994,151,1:1
返回顶部 每页显示:
共33页 首页 上一页 第1页 下一页 末页 /33 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费